The Role of Nanomaterials in the Treatment of Diseases and Their Effects on the Immune System
- PMID: 31316678
- PMCID: PMC6614262
- DOI: 10.3889/oamjms.2019.486
The Role of Nanomaterials in the Treatment of Diseases and Their Effects on the Immune System
Abstract
Nanotechnology has been widely exploited in recent years in various applications. Different sectors of medicine and treatment have also focused on the use of nanoproducts. One of the areas of interest in the treatment measures is the interaction between nanomaterials and immune system components. Engineered nanomaterials can stimulate the inhibition or enhancement of immune responses and prevent the detection ability of the immune system. Changes in immune function, in addition to the benefits, may also lead to some damage. Therefore, adequate assessment of the novel nanomaterials seems to be necessary before practical use in treatment. However, there is little information on the toxicological and biological effects of nanomaterials, especially on the potential ways of contacting and handling nanomaterials in the body and the body response to these materials. Extensive variation and different properties of nanomaterials have made it much more difficult to access their toxicological effects to the present. The present study aims to raise knowledge about the potential benefits and risks of using the nanomaterials on the immune system to design and safely employ these compounds in therapeutic purposes.
Keywords: Autoimmune diseases; Immune system; Nanomaterials; Nanomedicine; Nanotoxicology.
References
-
- Safaei M, Karimi N, Alavi M, Taran M. Application of nanomaterial in nutrition and food sciences. J Adv Appl Sci Res. 2017;1(12):1–16.
-
- Zhang L, Jiang Y, Ding Y, Povey M, York D. Investigation into the antibacterial behaviour of suspensions of ZnO nanoparticles (ZnO nanofluids) J Nanopart Res. 2007;9:479–489. https://doi.org/10.1007/s11051-006-9150-1.
-
- Safaei M, Taran M. Optimal conditions for producing bactericidal sodium hyaluronate-TiO2 bionanocomposite and its characterization. Int J Biol Macromol. 2017;104:449–456. https://doi.org/10.1016/j.ijbiomac.2017.06.016 PMid: 28619641. - PubMed
-
- Morigi V, Tocchio A, Bellavite Pellegrini C, Sakamoto JH, Arnone M, Tasciotti E. Nanotechnology in medicine: from inception to market domination. J Drug Deliv. 2012:389485. https://doi.org/10.1155/2012/389485 PMid: 22506121 PMCid: PMC3312282. - PMC - PubMed
-
- Goppert TM, Muller RH. Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns. J Drug Target. 2005;13:179–187. https://doi.org/10.1080/10611860500071292 PMid: 16036306. - PubMed
Publication types
LinkOut - more resources
Full Text Sources